United States Non Invasive Prenatal Testing Market Size, Share, and COVID-19 Impact Analysis, By Gestation Period (0-12 weeks, 13-24 weeks, and 25-35 weeks), By Risk (High & Average Risk and Low Risk), By Method (Biochemical Screening Tests and Cell-free DNA in Maternal Plasma Tests), By Technology (NGS, Array Technology, PCR, and Others), By Product (Consumables & Reagents and Instruments), By Application (Trisomy, Microdeletion Syndrome, and Others), By End-use (Hospitals & Clinics and Diagnostic Laboratories), and United States Non Invasive Prenatal Testing Market Insights, Industry Trend, Forecasts to 2033

Industry: Healthcare

RELEASE DATE Sep 2024
REPORT ID SI6083
PAGES 201
REPORT FORMAT PathSoft

Request Free Sample

Your personal details will remain secure and confidential - Privacy Policy

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies